VALIRX PLC Logo

VALIRX PLC

Life science company developing therapeutics for oncology and women's health.

VAL | IL

Overview

Corporate Details

ISIN(s):
GB00BLH13C52
LEI:
213800VQKB9SJCQDET40
Country:
United Kingdom
Address:
STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH

Description

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 12:10
Holding(s) in Company
English 52.9 KB
2025-11-24 17:05
Holding(s) in Company
English 52.8 KB
2025-11-24 10:40
Holding(s) in Company
English 21.0 KB
2025-11-20 13:25
Result of GM & Issue of Equity
English 58.4 KB
2025-11-13 15:30
Holding(s) in Company
English 21.0 KB
2025-11-10 08:25
Holding(s) in Company
English 21.0 KB
2025-11-04 18:30
Posting of Circular and Notice of General Meeting
English 41.5 KB
2025-11-04 08:20
Result of WRAP Retail Offer
English 25.2 KB
2025-10-30 08:21
WRAP Retail Offer for up to £300,000
English 34.2 KB
2025-10-30 08:17
Fundraising of up to £1,050,000
English 84.0 KB
2025-10-14 08:00
Inaphaea Commercial update
English 21.7 KB
2025-09-29 08:00
Half-year Report
English 291.2 KB
2025-09-18 08:00
Inaphaea Commercial Update
English 23.6 KB
2025-08-26 08:00
Commercial update
English 17.7 KB
2025-08-07 11:51
ValiRx Awarded Grant from Open University
English 16.2 KB

Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VALIRX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VALIRX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA
APTAMER GROUP PLC Logo
Develops custom affinity binders for research, diagnostics, and therapeutics.
United Kingdom
APTA
Aptevo Therapeutics Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for cancer.
United States of America
APVO
Biotech firm providing MICROPIG models, bio-resources, and non-clinical CRO services.
South Korea
149300
Aran Research & Development (1982) Ltd. Logo
A product design and development firm providing services from concept to manufacturing.
Israel
ARAN
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
ARTV
ARVINAS, INC. Logo
Clinical-stage biopharma developing therapeutics based on targeted protein degradation.
United States of America
ARVN
Asarina Pharma AB Logo
A biotechnology company in liquidation, formerly focused on neurosteroid therapies.
Sweden
ASAP
Atara Biotherapeutics, Inc. Logo
Develops off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
United States of America
ATRA
An integrated biologics development partner offering services from DNA sequence to cell bank.
South Korea
355690

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.